ACAD logo

ACADIA Pharmaceuticals (ACAD) Revenue

Annual Revenue

$726.44 M
+$209.20 M+40.45%

December 31, 2023


Summary


Performance

ACAD Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADprofitabilitymetrics:

Quarterly Revenue

$250.40 M
+$8.44 M+3.49%

September 30, 2024


Summary


Performance

ACAD Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

Related metrics

TTM Revenue

$929.24 M
+$38.70 M+4.35%

September 30, 2024


Summary


Performance

ACAD TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADprofitabilitymetrics:

ACAD Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+40.5%+18.3%+47.1%
3 y3 years+64.4%+90.3%+95.9%
5 y5 years+224.6%+164.7%+174.1%

ACAD Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+50.0%at high+116.9%at high+91.9%
5 y5-yearat high+114.2%at high+178.0%at high+174.1%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

ACADIA Pharmaceuticals Revenue History

DateAnnualQuarterlyTTM
Sep 2024
-
$250.40 M(+3.5%)
$929.24 M(+4.3%)
Jun 2024
-
$241.96 M(+17.6%)
$890.53 M(+9.4%)
Mar 2024
-
$205.83 M(-10.9%)
$813.81 M(+12.0%)
Dec 2023
$726.44 M(+40.4%)
$231.04 M(+9.1%)
$726.44 M(+15.0%)
Sep 2023
-
$211.70 M(+28.1%)
$631.89 M(+14.7%)
Jun 2023
-
$165.24 M(+39.5%)
$550.90 M(+5.9%)
Mar 2023
-
$118.46 M(-13.2%)
$520.23 M(+0.6%)
Dec 2022
$517.24 M(+6.8%)
$136.49 M(+4.4%)
$517.24 M(+1.1%)
Sep 2022
-
$130.71 M(-2.9%)
$511.50 M(-0.2%)
Jun 2022
-
$134.56 M(+16.5%)
$512.40 M(+3.9%)
Mar 2022
-
$115.47 M(-11.7%)
$493.06 M(+1.8%)
Dec 2021
$484.14 M(+9.6%)
$130.76 M(-0.6%)
$484.14 M(+2.1%)
Sep 2021
-
$131.61 M(+14.2%)
$474.39 M(+2.4%)
Jun 2021
-
$115.22 M(+8.1%)
$463.36 M(+1.1%)
Mar 2021
-
$106.55 M(-11.9%)
$458.24 M(+3.7%)
Dec 2020
$441.75 M(+30.3%)
$121.01 M(+0.4%)
$441.75 M(+5.4%)
Sep 2020
-
$120.58 M(+9.5%)
$419.07 M(+6.6%)
Jun 2020
-
$110.10 M(+22.2%)
$393.08 M(+7.3%)
Mar 2020
-
$90.07 M(-8.4%)
$366.19 M(+8.0%)
Dec 2019
$339.08 M(+51.5%)
$98.33 M(+4.0%)
$339.08 M(+12.9%)
Sep 2019
-
$94.59 M(+13.7%)
$300.32 M(+13.7%)
Jun 2019
-
$83.20 M(+32.2%)
$264.04 M(+11.0%)
Mar 2019
-
$62.96 M(+5.7%)
$237.90 M(+6.3%)
Dec 2018
$223.81 M(+79.2%)
$59.57 M(+2.2%)
$223.81 M(+7.7%)
Sep 2018
-
$58.30 M(+2.2%)
$207.80 M(+12.3%)
Jun 2018
-
$57.06 M(+16.8%)
$185.07 M(+16.8%)
Mar 2018
-
$48.87 M(+12.2%)
$158.48 M(+26.9%)
Dec 2017
$124.90 M(+620.7%)
$43.56 M(+22.4%)
$124.90 M(+33.9%)
Sep 2017
-
$35.58 M(+16.7%)
$93.30 M(+48.1%)
Jun 2017
-
$30.48 M(+99.4%)
$62.99 M(+93.1%)
Mar 2017
-
$15.29 M(+27.8%)
$32.61 M(+88.2%)
Dec 2016
$17.33 M(>+9900.0%)
$11.96 M(+127.1%)
$17.33 M(+221.8%)
Sep 2016
-
$5.27 M(+5330.9%)
$5.39 M(+3330.6%)
Jun 2016
-
$97.00 K(+2325.0%)
$157.00 K(+157.4%)
Mar 2016
-
$4000.00(-76.5%)
$61.00 K(0.0%)
Dec 2015
$61.00 K(-49.2%)
$17.00 K(-56.4%)
$61.00 K(-33.7%)
Sep 2015
-
$39.00 K(+3800.0%)
$92.00 K(+35.3%)
Jun 2015
-
$1000.00(-75.0%)
$68.00 K(-28.4%)
Mar 2015
-
$4000.00(-91.7%)
$95.00 K(-21.5%)
Dec 2014
$120.00 K(-89.5%)
$48.00 K(+220.0%)
$121.00 K(+10.0%)
Sep 2014
-
$15.00 K(-46.4%)
$110.00 K(-67.2%)
Jun 2014
-
$28.00 K(-6.7%)
$335.00 K(-55.8%)
Mar 2014
-
$30.00 K(-18.9%)
$758.00 K(-33.8%)
Dec 2013
$1.15 M
$37.00 K(-84.6%)
$1.15 M(-23.1%)
Sep 2013
-
$240.00 K(-46.8%)
$1.49 M(-68.5%)
DateAnnualQuarterlyTTM
Jun 2013
-
$451.00 K(+8.2%)
$4.73 M(-3.0%)
Mar 2013
-
$417.00 K(+9.7%)
$4.87 M(-0.7%)
Dec 2012
$4.91 M(+137.4%)
$380.00 K(-89.1%)
$4.91 M(-4.1%)
Sep 2012
-
$3.48 M(+480.6%)
$5.12 M(+130.3%)
Jun 2012
-
$599.00 K(+33.1%)
$2.22 M(+6.7%)
Mar 2012
-
$450.00 K(-23.5%)
$2.08 M(+0.7%)
Dec 2011
$2.07 M(-95.1%)
$588.00 K(+0.7%)
$2.07 M(-94.4%)
Sep 2011
-
$584.00 K(+27.0%)
$36.88 M(-4.4%)
Jun 2011
-
$460.00 K(+5.7%)
$38.60 M(-4.5%)
Mar 2011
-
$435.00 K(-98.8%)
$40.44 M(-4.0%)
Dec 2010
$42.13 M(+558.5%)
$35.40 M(+1438.6%)
$42.13 M(+395.7%)
Sep 2010
-
$2.30 M(+0.2%)
$8.50 M(-1.6%)
Jun 2010
-
$2.30 M(+7.7%)
$8.63 M(+5.8%)
Mar 2010
-
$2.13 M(+20.6%)
$8.16 M(+27.5%)
Dec 2009
$6.40 M(+302.5%)
$1.77 M(-27.4%)
$6.40 M(+29.1%)
Sep 2009
-
$2.44 M(+33.8%)
$4.95 M(+76.9%)
Jun 2009
-
$1.82 M(+386.6%)
$2.80 M(+141.9%)
Mar 2009
-
$374.00 K(+15.1%)
$1.16 M(-27.2%)
Dec 2008
$1.59 M(-79.0%)
$325.00 K(+15.2%)
$1.59 M(-44.2%)
Sep 2008
-
$282.00 K(+59.3%)
$2.85 M(-37.0%)
Jun 2008
-
$177.00 K(-78.0%)
$4.52 M(-29.3%)
Mar 2008
-
$806.00 K(-49.1%)
$6.40 M(-15.3%)
Dec 2007
$7.55 M(-7.1%)
$1.58 M(-19.1%)
$7.55 M(-2.5%)
Sep 2007
-
$1.96 M(-4.8%)
$7.75 M(+0.2%)
Jun 2007
-
$2.06 M(+4.8%)
$7.73 M(+2.3%)
Mar 2007
-
$1.96 M(+10.5%)
$7.56 M(-7.1%)
Dec 2006
$8.13 M(-25.8%)
$1.77 M(-8.7%)
$8.13 M(-7.6%)
Sep 2006
-
$1.94 M(+3.3%)
$8.80 M(-16.4%)
Jun 2006
-
$1.88 M(-25.9%)
$10.53 M(-5.7%)
Mar 2006
-
$2.54 M(+3.8%)
$11.17 M(+1.9%)
Dec 2005
$10.96 M(+138.0%)
$2.44 M(-33.5%)
$10.96 M(+14.2%)
Sep 2005
-
$3.67 M(+46.0%)
$9.60 M(+27.9%)
Jun 2005
-
$2.52 M(+8.2%)
$7.50 M(+25.0%)
Mar 2005
-
$2.33 M(+114.7%)
$6.01 M(+30.4%)
Dec 2004
$4.60 M(-37.6%)
$1.08 M(-31.5%)
$4.60 M(-14.2%)
Sep 2004
-
$1.58 M(+55.7%)
$5.37 M(-4.7%)
Jun 2004
-
$1.02 M(+9.9%)
$5.63 M(-18.4%)
Mar 2004
-
$923.90 K(-49.9%)
$6.89 M(-11.8%)
Dec 2003
$7.38 M(+17.6%)
$1.84 M(0.0%)
$7.82 M(+30.9%)
Sep 2003
-
$1.84 M(-19.1%)
$5.98 M(+44.7%)
Jun 2003
-
$2.28 M(+23.3%)
$4.13 M(+123.3%)
Mar 2003
-
$1.85 M
$1.85 M
Dec 2002
$6.28 M(+69.0%)
-
-
Dec 2001
$3.71 M(-13.9%)
-
-
Dec 2000
$4.31 M
-
-

FAQ

  • What is ACADIA Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual revenue year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?
  • What is ACADIA Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals TTM revenue year-on-year change?

What is ACADIA Pharmaceuticals annual revenue?

The current annual revenue of ACAD is $726.44 M

What is the all time high annual revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual revenue is $726.44 M

What is ACADIA Pharmaceuticals annual revenue year-on-year change?

Over the past year, ACAD annual revenue has changed by +$209.20 M (+40.45%)

What is ACADIA Pharmaceuticals quarterly revenue?

The current quarterly revenue of ACAD is $250.40 M

What is the all time high quarterly revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly revenue is $250.40 M

What is ACADIA Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, ACAD quarterly revenue has changed by +$38.70 M (+18.28%)

What is ACADIA Pharmaceuticals TTM revenue?

The current TTM revenue of ACAD is $929.24 M

What is the all time high TTM revenue for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high TTM revenue is $929.24 M

What is ACADIA Pharmaceuticals TTM revenue year-on-year change?

Over the past year, ACAD TTM revenue has changed by +$297.35 M (+47.06%)